Microbial cancer immunotherapy reprograms hematopoietic stem cells to enhance anti-tumor immunity
Andrew W. Daman, Anthony C. Antonelli, Gil Redelman‐Sidi, Lucinda Paddock, Shireen Khayat, Mythili Ketavarapu, Jin‐Gyu Cheong, Leonardo F. Jurado, Anna Benjamin, Song Jiang, Dughan J. Ahimovic, Victoria R. Lawless, Michael J. Bale, Oleg Loutochin, Victor A. McPherson, , Michael S. Glickman
This study shows that bladder BCG immunotherapy reprograms hematopoietic stem cells to enhance anti-tumor immunity in mice and humans.
Cancer Cell · Mar 21, 2024Peer-reviewedImmunology